Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Encompass Health (EHC)

NYSE Health Care Health Care Facilities S&P MidCap 400
$137.54
-3.73 (-2.64%)
Close of Nov 06, 2026 · end-of-day data

EHC 8-K filings in 2024

Every material Form 8-K Encompass Health filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.

Briefs in 2024117 on record in all
Latest filing in 2024Oct 28, 2024guidance
High impact (4-5)1of 1 brief
TonePositive1
Oct 28, 4:33 PM ET

Encompass Health raises 2024 guidance as Q3 revenue rises 11.9% to $1.35 billion

Positive guidance Written later 2.027.01

Encompass Health reported third-quarter 2024 net operating revenue of $1.35 billion, up 11.9% from a year earlier, and diluted earnings per share from continuing operations of $1.07, up from $0.85. The company raised its full-year 2024 guidance for revenue, Adjusted EBITDA and adjusted earnings per share, though it noted challenging conditions from Hurricanes Helene and Milton.

  • Q3 2024 net operating revenue was $1,351.0 million versus $1,206.9 million in Q3 2023; discharges rose 8.8%, including 6.8% same-store growth.
  • Adjusted EBITDA was $269.3 million, up 13.4%; adjusted earnings per share was $1.03 versus $0.86.
  • Full-year 2024 guidance raised: net operating revenue to $5,325 million to $5,375 million (from $5,275 million to $5,350 million) and adjusted EBITDA to $1,070 million to $1,090 million (from $1,040 million to $1,075 million).
  • Adjusted earnings per share guidance raised to $4.19 to $4.33 from $3.97 to $4.22; earnings call is at 10:00 a.m. Eastern on October 29, 2024.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Encompass Health filing is on SEC EDGAR ↗. 8-K briefs of other companies →